Comments
Roche breast cancer drug extends overall survival
09.12.2012. | ZURICH (Reuters) - Swiss pharma group Roche's drug Perjeta significantly extended the lives of women with an aggressive and incurable form of breast cancer compared to a placebo, according to new data from a late-stage study presented on Saturday....